Atlas Trials

Compare the Accuracy of ctDNA-MRD and MVI Result in Predicting Postoperative Recurrence of Hepatocellular Carcinoma

Clinical trial NCT06449846 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06449846
Sponsor
Zhujiang Hospital
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Hepatocellular Carcinoma ResectableSurgeryRecurrence
Start date
2024-06-01
Primary completion
2026-12-31
Enrollment
152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.